Jean Luc Herbeaux Steps Down as CEO of Hovione

Hovione’s Chief Executive Officer (CEO) Dr. Jean Luc Herbeaux has decided to step down from his role, effective May 21, 2026. He will continue with the company until September 30, 2026.

A succession process to appoint the company’s new Chief Executive Officer has been initiated. In the meantime, the Board has appointed António Almeida (currently Chief Financial Officer) and Dr. Marco Gil (currently Senior VP Sales & Marketing) as co-Chief Executive Officers, effective as of May 21, 2026.

Both executives are long-standing members of Hovione’s Global Leadership Team and have played key roles in the company’s growth and operations over many years. They bring extensive knowledge of the business, strong operational expertise, and established relationships across the organization, customers, and partners.

“Hovione remains strongly positioned for the future, with a clear strategy, a strong leadership team, and a continued commitment to operational excellence and innovation,” said Dr. Stefan Doboczky, Chairman of the Board of Directors, Hovione. “We are confident in the company’s ability to continue delivering for customers, partners, and other stakeholders throughout this transition and beyond.”

About António Almeida

Almeida has more than 30 years of international experience in finance and 20 years in the pharmaceutical CDMO industry. He started his career at Siemens in 1994, where he held several positions of increasing responsibility across Portugal and Germany until 2007.

Almeida joined Hovione in 2007 as Group Controller and played a key role in supporting the company’s international growth and operational expansion. In 2014, he was appointed Chief Financial Officer, leading Hovione’s global financial strategy and overseeing the company’s finance organization across multiple geographies.

Almeida holds a degree in Business Management from Lusíada University.

About Dr. Marco Gil

Gil has over 20 years of experience in the pharmaceutical CDMO industry. Since joining Hovione in 2007, he has held several senior management positions, including Director of R&D Process Chemistry and Site General Manager of Hovione’s New Jersey facility in the United States, where he led operations and strategic growth initiatives in one of the company’s key markets. Between 2017 and 2022, Gil held leadership roles in Sales and Business Development, contributing to the expansion of Hovione’s integrated offering and global customer partnerships. Since May 2022, he has served as Senior Vice-President of Sales & Marketing, leading Hovione’s global commercial strategy and market positioning.

Gil holds a degree in Chemical Engineering and a Ph.D. in Chemistry from the Technical University of Lisbon.